- $11.40bn
- $11.47bn
- $2.88bn
- 86
- 33
- 72
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,787 | 1,822 | 2,289 | 2,792 | 2,881 |
Cost of Revenue | |||||
Gross Profit | 1,317 | 1,382 | 1,657 | 1,918 | 2,079 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,634 | 1,642 | 1,954 | 2,322 | 2,421 |
Operating Profit | 153 | 180 | 335 | 470 | 460 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 147 | 176 | 333 | 468 | 466 |
Provision for Income Taxes | |||||
Net Income After Taxes | 114 | 138 | 253 | 357 | 355 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 114 | 138 | 253 | 357 | 355 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 114 | 138 | 253 | 357 | 355 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.3 | 5.13 | 9.37 | 13.4 | 13.3 |